American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ZyVersa Therapeutics, Inc. (ZVSA)

$0.12 +5.45% OTC: ZVSA · 15-min delayed

LIGHTHOUSE POINT, Florida
Public · OTC: ZVSA

Visit website Follow

-$25.0MNet income

ZVSAOTC

About ZyVersa Therapeutics, Inc.

ZYVERSA THERAPEUTICS INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: ZVSA
Headquarters: LIGHTHOUSE POINT, Florida
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: ZVSA OTC
SEC CIK: 1859007
EIN: 862685744
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show ZyVersa Therapeutics, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/zyversa-therapeutics-inc/"><img src="https://americancompanies.com/badge/zyversa-therapeutics-inc.svg" alt="ZyVersa Therapeutics, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow ZyVersa Therapeutics, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: -$25.0M
Total assets: $347.9K
Operating margin: 3385.8%
Net margin: 3488.3%

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

FY2023

FY2024

Revenue Net income

FY 2024

Financial statements

Income statement

Revenue: -$269.9K
Operating expenses: $9.1M
Operating income: -$9.1M
Income tax: $6.7K
Net income: -$9.4M
EPS (basic): $-8.48
EPS (diluted): $-8.48

Balance sheet

Total assets: $20.6M
Current assets: $1.7M
Total liabilities: $12.1M
Current liabilities: $11.2M
Shareholders’ equity: $8.5M

Cash flow

Operating cash flow: -$7.6M
Investing cash flow: $1.6M
Financing cash flow: $6.0M
Net cash flow: $0

Statements via Polygon.io (SEC filings)

OTC: ZVSA

$0.12 +5.45%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.11 $0.78

52-week range

EPS (diluted): $-8.48
Open: —
Day range: –
Prev close: —
Volume: —

ZyVersa Therapeutics, Inc. (ZVSA) Stock Price

Reported a net loss of $25.0M.
Trading 85% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ZyVersa Therapeutics, Inc..

Write a review

Newsroom

News about ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update GlobeNewswire Inc. · 2024-08-09 · positive ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update GlobeNewswire Inc. · 2024-05-15 ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention GlobeNewswire Inc. · 2024-05-14 ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer’s Disease GlobeNewswire Inc. · 2024-04-29 ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes GlobeNewswire Inc. · 2024-04-04 ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update GlobeNewswire Inc. · 2024-03-25

News & sentiment via Polygon.io

FAQ

ZyVersa Therapeutics, Inc.: frequently asked questions

Is ZyVersa Therapeutics, Inc. an American company?

ZyVersa Therapeutics, Inc. is a US-based company headquartered in Lighthouse Point, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is ZyVersa Therapeutics, Inc. headquartered?

ZyVersa Therapeutics, Inc. is headquartered in Lighthouse Point, Florida, United States.

Is ZyVersa Therapeutics, Inc. publicly traded?

Yes — ZyVersa Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ZVSA on the OTC.

What does ZyVersa Therapeutics, Inc. do?

ZyVersa Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore